Editorial: Optimization and expansion of predictive models for barrett's esophagus and esophageal adenocarcinoma: Could a life-course exposure history be beneficial

American Journal of Gastroenterology

Volumn 108, Issue 6, 2013, Pages 923-925

  Cook, Michael B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; BODY MASS; COLONOSCOPY; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GASTROESOPHAGEAL REFLUX QUESTIONNAIRE; HUMAN; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK FACTOR; SCREENING; FEMALE; MALE; NOTE;

BARRETT ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE;

EID: 84878905221     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.83     Document Type: Review

References (32)

1. Omer ZB, Ananthakrishnan AN, Nattinger KJ et al. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol 2012 ; 10 : 722-7.
2. Menon S, Jayasena H, Nightingale P et al. Infl uence of age and sex on endoscopic fi ndings of gastrooesophageal refl ux disease: an endoscopy database study. Eur J Gastroenterol Hepatol 2011 ; 23 : 389-95.
3. Shaheen N. Is there a " Barrett's iceberg? ". Gastroenterology 2002 ; 123 : 636-9.
4. Th rift AP, Kramer JR, Qureshi Z et al. Age at onset of GERD symptoms predicts risk of Barrett ' s esophagus. Am J Gastroenterol 2013 ; 108 : 915-22 (this issue).
5. Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal refl ux disease. Mayo Clinic Proc 1994 ; 69 : 539-47. (Pubitemid 24164694)
6. Westhoff B, Brotze S, Weston A et al. Th e frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005 ; 61 : 226-31. (Pubitemid 40261070)
7. Eloubeidi MA, Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal refl ux disease: a multivariable analysis in veterans.[see comment]. J Clin Gastroenterol 2001 ; 33 : 306-9. (Pubitemid 32880970)
8. Johansson J, Hakansson HO, Mellblom L et al. Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol 2007 ; 42 : 148-56.
9. Smith KJ, O ' Brien SM, Smithers BM et al. Interactions among smoking, obesity, and symptoms of acid refl ux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2005 ; 14 : 2481-6. (Pubitemid 41752705)
10. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997 ; 92 : 1293-7.
11. Eisen GM, Sandler RS, Murray S et al. Th e relationship between gastroesophageal refl ux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997 ; 92 : 27-31. (Pubitemid 27027023)
12. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic fi ndings in GERD? Gastrointest Endosc 2003 ; 58 : 661-70. (Pubitemid 37370477)
13. Gerson LB, Edson R, Lavori PW et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal refl ux. Am J Gastroenterol 2001 ; 96 : 2005-12. (Pubitemid 32660890)
14. Th rift AP, Kendall BJ, Pandeya N et al. A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) 2012 ; 5 : 1115-23.
15. Taylor JB, Rubenstein JH. Meta-analyses of the eff ect of symptoms of gastroesophageal refl ux on the risk of Barrett's esophagus. Am J Gastroenterol 2010 ; 105 : 1729, 1730-1737 ;quiz 1738.
16. Esquivel RF, Boolchand V, Kumar N et al. Th e prevalence of Barrett's esophagus in veteran patients with and without GERD symptoms undergoing outpatient colonoscopy. Gastrointest Endosc 2008 ; 67 : AB172.
17. Zagari RM, Fuccio L, Wallander MA et al. Gastro-oesophageal refl ux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008 ; 57 : 1354-9.
18. Ronkainen J, Aro P, Storskrubb T et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005 ; 129 : 1825-31. (Pubitemid 41772961)
19. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003 ; 125 : 1670-7. (Pubitemid 37500431)
20. Rubenstein JH, Morgenstern H, Appelman H et al. Prediction of Barrett's esophagus among men. Am J Gastroenterol 2013 ; 108 : 353-62.
21. Ward EM, Wolfsen HC, Achem SR et al. Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of refl ux symptoms. Am J Gastroenterol 2006 ; 101 : 12-7. (Pubitemid 43381703)
22. Varghese S, Lao-Sirieix P, Fitzgerald RC. Identifi cation and clinical implementation of biomarkers for Barrett's esophagus. Gastroenterology 2012 ; 142 : 435-41 e2.
23. Benaglia T, Sharples LD, Fitzgerald RC et al. Health benefi ts and cost eff ectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. Gastroenterology 2013 ; 144 : 62-73 e6.
24. Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol 2012 ; 9 : 278-87.
25. Bird-Lieberman EL, Dunn JM, Coleman HG et al. Population-based study reveals new risk-stratifi cation biomarker panel for Barrett's esophagus. Gastroenterology 2012 ; 143 : 927-35 e3.
26. Gora MJ, Sauk JS, Carruth RW et al. Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med 2013 ; 19 : 238-40.
27. Th rift AP, Kendall BJ, Pandeya N et al. A model to determine absolute risk for esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013 ; 11 : 138-44 e2.
28. Sato F, Jin Z, Schulmann K et al. Th ree-tiered risk stratifi cation model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One 2008 ; 3 : e1890.
29. Bergman J, Vieth M, Fitzgerald RC. Let's not jump to conclusions regarding low-grade dysplasia in Barrett's esophagus. G astroenterology 2 012; 1 42: E 18-9.
30. Wani S, Falk G, Sharma P. Let's not jump to conclusions regarding low-grade dysplasia in Barrett's esophagus: Reply. Gastroenterology 2012 ; 142 : E19-20.
31. Wani S, Falk GW, Post J et al. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology 2011 ; 141 : 1179-U590.
32. Curvers WL, ten Kate FJ, Krishnadath KK et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010 ; 105 : 1523-30.